-
Uncategorized2 months agoAC Immune and Lilly reach agreement on drug collaboration
Biopharmaceutical company AC Immune has reached an amended agreement with Eli Lilly for the development of an Alzheimer’s treatment. The amendment to the 2018 license includes...
-
Uncategorized2 months ago
Inside the Talkspace-Universal Health Services deal
After a flashy debut during the height of the Covid-19 pandemic, Talkspace, like many other virtual mental health companies, struggled to keep the momentum going. That...
-
Uncategorized2 months ago
Childhood Dementia Explained by Synaptic Dysfunction, Opens New Therapies
In a new study published in Nature Communications titled, “Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks,” researchers from Flinders University in Adelaide have uncovered how...
-
Uncategorized2 months agoSTAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far. It is an accomplishment, after all. The next step is...
-
Uncategorized2 months ago
In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient
A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, providing further proof of the...
-
Uncategorized2 months ago
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
-
Uncategorized2 months ago
David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapy
A startup developing a one-time treatment that could rewind the clock on dying cells announced a major influx of funding. Life Biosciences, a startup co-founded by...
-
Uncategorized2 months agoWhat does MAHA look like these days?
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’ve got a couple fun programming...
-
Uncategorized2 months ago
ADC biotech Sidewinder collects $137M for bispecific approach
A San Diego biotech looking to double up on the power of antibody-drug conjugates with fewer toxicities has patched together a $137 million Series B from...
-
Uncategorized2 months ago
Medline hit with FDA warning letter over defective heart syringes, safety hazards
After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns being leveled by the FDA.
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
